It is possible that estrogen could induce the expression of FTO (the fat mass and obesity-associated gene), in a manner that is depending on ESR1 (ESRα), promoting the proliferation of endometrial cancer cells [31]. The gene discussed is ESR1; the disease is obesity due to melanocortin 4 receptor deficiency.